Table 2.
Excess TB incidence and deaths between 2020 and 2025 as a result of the different scenarios for COVID-related lockdowns.
| Country | Excess cases between 2020 and 2025 | Excess deaths between 2020 and 2025 | ||
| (% increase) [95% CrI] | (% increase) [95% CrI] | |||
| 2-month suspension + 2-month restoration | 3-month suspension + 10-month restoration | 2-month suspension + 2-month restoration | 3-month suspension + -month restoration | |
| India | 182,000 [159,000–211,000] | 1190,000 [1060,000–1330,000] | 83,600 [77,500–90,600] | 361,000 [333,000–394,000] |
| (1.43% [1.30–1.65%]) | (9.25% [8.53–10.40%]) | (3.65% [3.48–3.95%]) | (15.70% [15–16.80%]) | |
| Kenya | 489 [−2660–5720] | 24,700 [16,100–44,700] | 2460 [1590–3840] | 12,500 [8790–17,800] |
| (0.0076% [−0.35–0.81%]) | (3.36% [2.28–6.11%]) | (1.30% [0.86–2.30%]) | (6.58% [5.30–10.0%]) | |
| Ukraine | 835 [−460–1520] | 4350 [826–6540] | 332 [153–570] | 1340 [815–1980] |
| (0.60% [−0.30–1.03%]) | (2.96%[0.52–4.47%]) | (1.15% [0.55–1.73%]) | (4.64% [2.84–6.27%]) | |